Cargando…

Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?

Communications between clinicians and patients with idiopathic pulmonary fibrosis (IPF) have the potential to be challenging. The variable course and poor prognosis of IPF complicate discussions around life expectancy but should not prevent clinicians from having meaningful conversations about patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijsenbeek, Marlies S., Bonella, Francesco, Orsatti, Leticia, Russell, Anne-Marie, Valenzuela, Claudia, Wuyts, Wim A., Baile, Walter F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784894/
https://www.ncbi.nlm.nih.gov/pubmed/35083325
http://dx.doi.org/10.1183/23120541.00422-2021
_version_ 1784638841914654720
author Wijsenbeek, Marlies S.
Bonella, Francesco
Orsatti, Leticia
Russell, Anne-Marie
Valenzuela, Claudia
Wuyts, Wim A.
Baile, Walter F.
author_facet Wijsenbeek, Marlies S.
Bonella, Francesco
Orsatti, Leticia
Russell, Anne-Marie
Valenzuela, Claudia
Wuyts, Wim A.
Baile, Walter F.
author_sort Wijsenbeek, Marlies S.
collection PubMed
description Communications between clinicians and patients with idiopathic pulmonary fibrosis (IPF) have the potential to be challenging. The variable course and poor prognosis of IPF complicate discussions around life expectancy but should not prevent clinicians from having meaningful conversations about patients’ fears and needs, while acknowledging uncertainties. Patients want information about the course of their disease and management options, but the provision of information needs to be individualised to the needs and preferences of the patient. Communication from clinicians should be empathetic and take account of the patient's perceptions and concerns. Models, tools and protocols are available that can help clinicians to improve their interactions with patients. In this article, we consider the difficulties inherent in discussions with patients with IPF and their loved ones, and how clinicians might communicate with patients more effectively, from breaking the news about the diagnosis to providing support throughout the course of the disease.
format Online
Article
Text
id pubmed-8784894
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-87848942022-01-25 Communicating with patients with idiopathic pulmonary fibrosis: can we do it better? Wijsenbeek, Marlies S. Bonella, Francesco Orsatti, Leticia Russell, Anne-Marie Valenzuela, Claudia Wuyts, Wim A. Baile, Walter F. ERJ Open Res Review Communications between clinicians and patients with idiopathic pulmonary fibrosis (IPF) have the potential to be challenging. The variable course and poor prognosis of IPF complicate discussions around life expectancy but should not prevent clinicians from having meaningful conversations about patients’ fears and needs, while acknowledging uncertainties. Patients want information about the course of their disease and management options, but the provision of information needs to be individualised to the needs and preferences of the patient. Communication from clinicians should be empathetic and take account of the patient's perceptions and concerns. Models, tools and protocols are available that can help clinicians to improve their interactions with patients. In this article, we consider the difficulties inherent in discussions with patients with IPF and their loved ones, and how clinicians might communicate with patients more effectively, from breaking the news about the diagnosis to providing support throughout the course of the disease. European Respiratory Society 2022-01-24 /pmc/articles/PMC8784894/ /pubmed/35083325 http://dx.doi.org/10.1183/23120541.00422-2021 Text en Copyright ©The authors 2022 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Review
Wijsenbeek, Marlies S.
Bonella, Francesco
Orsatti, Leticia
Russell, Anne-Marie
Valenzuela, Claudia
Wuyts, Wim A.
Baile, Walter F.
Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?
title Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?
title_full Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?
title_fullStr Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?
title_full_unstemmed Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?
title_short Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?
title_sort communicating with patients with idiopathic pulmonary fibrosis: can we do it better?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784894/
https://www.ncbi.nlm.nih.gov/pubmed/35083325
http://dx.doi.org/10.1183/23120541.00422-2021
work_keys_str_mv AT wijsenbeekmarliess communicatingwithpatientswithidiopathicpulmonaryfibrosiscanwedoitbetter
AT bonellafrancesco communicatingwithpatientswithidiopathicpulmonaryfibrosiscanwedoitbetter
AT orsattileticia communicatingwithpatientswithidiopathicpulmonaryfibrosiscanwedoitbetter
AT russellannemarie communicatingwithpatientswithidiopathicpulmonaryfibrosiscanwedoitbetter
AT valenzuelaclaudia communicatingwithpatientswithidiopathicpulmonaryfibrosiscanwedoitbetter
AT wuytswima communicatingwithpatientswithidiopathicpulmonaryfibrosiscanwedoitbetter
AT bailewalterf communicatingwithpatientswithidiopathicpulmonaryfibrosiscanwedoitbetter